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a b s t r a c t
Biological responses ofmulti-wall carbonnanotubes (MWCNTs)were assessed after a single intratracheal
instillation in rats. Thediameter andmedian lengthof theMWCNTsused in this studywereapproximately
60nm and 1.5m, respectively. Groups of male Sprague–Dawley rats were intratracheally instilled with
0.04, 0.2, or 1mg/kg of the individually dispersedMWCNT suspension. After instillation, the bronchoalve-
olar lavage ﬂuid was assessed for inﬂammatory cells and markers, and the lung, liver, kidney, spleen,
and cerebrum were histopathologically evaluated at 3-day, 1-week, 1-month, 3-month, and 6-month
post-exposure. Transient pulmonary inﬂammatory responses were observed only in the lungs of the
group of rats exposed to 1mg/kg of MWCNTs. Morphology of the instilled MWCNTs in the lungs of rats
was assessed using light microscopy and transmission electron microscopy (TEM). Light microscopyntratracheal instillation examination revealed that MWCNTs deposited in the lungs of the rats were typically phagocytosed by
the alveolar macrophages and these macrophages were consequently accumulated in the alveoli until
6-month post-exposure. The 400 TEM images obtained showed that all MWCNTs were located in the
alveolar macrophages or macrophages in the interstitial tissues, and MWCNTs were not located in the
cells of the interstitial tissues. There was no evidence of chronic inﬂammation, such as angiogenesis or
ﬁbrosis, induced by MWCNT instillation. These results suggest that MWCNTs were being processed and
phag
. cleared by alveolar macro
. Introduction
Carbon nanotubes (CNTs) are ﬁber-shaped substances that con-
ist of graphite hexagonal-mesh planes (graphene sheet) present
s a single-layer or as multi-layers with nest accumulation.
ubes with single-wall structures and multi-wall structures are
alled single-wall carbon nanotubes (SWCNTs) andmulti-wall car-
on nanotubes (MWCNTs), respectively. CNTs are regarded as
anomaterials because their diameters are within the nanoscale
ange (1–100nm). Currently, various applied studies are focusing
n CNTs because of their excellent physical–chemical proper-
ies.However, there is a growing concern regarding the hazards of
NTs. Many pulmonary toxicity studies (e.g., inhalation exposure
tudies, intratracheal instillation studies, and pharyngeal aspira-
ion studies) have reported that multifocal granulomas or ﬁbrotic
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responses were persistently observed in the lungs of rats and mice
after SWCNT exposure (Warheit et al., 2004; Lam et al., 2004;
Mangum et al., 2006; Chou et al., 2008; Miyawaki et al., 2008;
Shvedova et al., 2005, 2007, 2008a,b). MWCNT pulmonary toxicity
studies also reported similar pulmonary responses as SWCNTexpo-
sure. Granulomatous inﬂammation and ﬁbrotic responses were
reported in MWCNT inhalation exposure studies (Muller et al.,
2005; Li et al., 2007; Ma-Hock et al., 2009; Pauluhn, 2010).
The major concerns of CNT toxicity are that those objects are
nanoscaled, andmore importantly, they are ﬁber-shaped (i.e., they
may have asbestos-like properties). Takagi et al. (2008) reported
that most p53+/− transgenic mice died owing mesothelioma up
to 180 days after intraperitoneal injection of MWCNTs at a dose
of 3mg/mouse (approximately 100mg/kg body weight). Poland et
al. (2008) reported that inﬂammatory responses were observed in
mice exposed to ﬁbers longer than 15m, but not in those exposed
Open access under CC BY-NC-ND licenseto shorter ﬁbers, at 1 and 7 days after intraperitoneal injection
of MWCNTs, asbestos, or carbon black particles at 50g/mouse.
In a more recent intraperitoneal injection study with MWCNTs,
however, there was no signiﬁcant increase in the incidence of
mesothelioma at doses of 2 and 20mg/rat, even 2 years after injec-
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ion, although the incidence of mesothelioma was signiﬁcantly
ncreased after administration of crocidolite (Muller et al., 2009).
In most CNT toxicity studies, CNT agglomerates were used as
he test samples. However, some studies indicate that dispersed
NTs are more toxic than agglomerated CNTs when inhaled or
nstilled into the lungs of experimental animals.Muller et al. (2005)
eported that MWCNT samples ground by a ball mill induced
reater inﬂammation than non-ground bulkMWCNT samples after
ntratracheal instillation in rats. In their reports, the average length
f the MWCNT samples was greatly decreased from 5.9 to 0.7m
ecause of the ball mill grounding; but major characteristics such
s the diameter or surface area did not change. Mercer et al. (2008)
eported that after pharyngeal aspiration exposure of mice to dis-
ersed SWCNTs (average particle size, 0.69m) and non-dispersed
WCNTs (average particle size, 15.2m), thickening of the alveolar
alls was observed only in the group exposed to dispersed SWC-
Ts. Mercer et al. (2008) concluded that the dispersed SWCNTs
ere rapidly incorporated into the alveolar interstitium. Porter et
l. (2010) suggested that the dispersed MWCNTs could reach the
leura after pharyngeal aspiration exposure inmice. These ﬁndings
ndicate that toxicity studies using agglomerated CNTs are inade-
uate to evaluate the hazards and risks of CNTs. However, there
re few toxicity studies with dispersed CNTs. Further, there is little
nformation regarding the behavior of MWCNTs after deposition in
he lungs.
There are many potential applications of MWNCTs (e.g., in
lectrically conducting ceramics, anti-static clothing, and heat-
xchange materials, etc.). To explore these applications, MWCNT
ispersion is a key factor. Extensive research onMWCNTdispersion
s underway in several organizations. Therefore, it is possible that
xposures to dispersed MWCNTs might occur in the near future,
ecessitating the evaluationof thehazards of exposure todispersed
WCNTs.
In this study, individually dispersed MWCNTs were intra-
racheally instilled in rats, and the biological responses (e.g.,
ulmonary inﬂammation) were assessed. Further, light micro-
copic and transmission electron microscopic examinations were
erformed to evaluate the behavior of MWCNTs in the lungs.
. Materials and methods
.1. Sample preparation
MWCNT samples (MWNT-7, Lot#T050831-01) were purchased from Mitsui &
o. Ltd. (Tokyo, Japan). MWNT-7 is a highly pure MWCNT sample, in which the
arbon content is 99.79% (determined by ﬂuorescence X-ray analysis). MWNT-7
as been used in many toxicity studies such as those by Takagi et al. (2008) and
oland et al. (2008). MWNT-7 is produced as a dry powder and the tubes do not
ggregate together. To disperse MWCNTs in liquid for intratracheal instillation,
WCNTs (0.04, 0.2, or 1mg/mL) and a maximum of 10mg/mL of polyoxyethy-
ene sorbitan monooleate (Tween 80, Wako Pure Chemical Industries, Ltd., Osaka,
apan) were added to Milli-Q water (Millipore Corporation, Billerica, MA, USA) and
hen ultrasonicated using an ultrasonic bath (5510J-MT, Branson Ultrasonics Div.
f Emerson Japan, Ltd., Kanagawa, Japan) for 90min at 135W and a frequency of
2 kHz. PBS (10mM)was then added to the ultrasonicatedMWCNT suspension. The
bove MWCNT suspensions were used for intratracheal instillation the day after
heir preparation.
Tween 80 (10mg/mL) in PBS (10mM) was used as the negative (vehicle) con-
rol. Min-U-Sil 5 crystalline silica particles (US Silica Co., Berkley Springs, WV,
SA), which produce continuous pulmonary inﬂammation in the lungs of rats with
mg/kg of intratracheal instillation (Warheit et al., 2006, 2007a,b; Kobayashi et
l., 2009), was used as the positive control and was prepared as described for
he MWCNT suspension. The concentration of the crystalline silica particles was
djusted to 5mg/mL for intratracheal instillation..2. MWCNT characterization
For both the bulkMWCNT samples andMWCNT suspensions, the agglomeration
tate andﬁber lengthwere evaluatedbasedonobservationusing a scanningelectron
icroscope (SEM) (SM-5410, JEOL Ltd., Tokyo, Japan) and a transmission electron
icroscope (TEM) (TM-1010, JEOL Ltd., Tokyo, Japan).y 276 (2010) 143–153
The BET surface area was measured by the N2-adsorption method using
Autosorb (Quantachrome Instrument, Boynton Beach, FL, USA) at a pressure ranging
from10.3 to 31.4 kPa. Purity of theMWCNT sampleswasmeasured by thermogravi-
metric analysis (TGA) using an auto simultaneous TG/DTA instrument (DTG-60H,
Shimadzu Corporation, Kyoto, Japan). Furthermore, presence of defects in the
graphene structure of the bulk MWCNT samples and the MWCNT suspensions was
evaluated by Raman spectroscopy analysis (Nicolet Almega XR micro-Raman sys-
tem, Thermo Fisher Scientiﬁc Inc., Japan). The resonance Raman scattering spectra
were measured in the frequency regions of 100–3000 cm−1 with excitation wave-
length at 532nm.
The MWCNT suspension was characterized within 1 week of sample prepa-
ration. This is because we had monitored the time-dependent changes in the
agglomeration state of theMWCNTs in the suspension using laser diffraction (Helos,
Sympatec, Clausthal-Zellerfeld, Germany), and no signiﬁcant difference was noted
in the equivalent diameters of MWCNTs within 1 week of sample preparation.
2.3. Experimental animals
In this study, 8-week-oldmale Crl:CD(SD) rats (Charles River Laboratories Japan,
Inc., Yokohama, Japan)wereused. The ratswerekept inananimal facility andhoused
in positive-pressure air-conditioned units (21–24 ◦C, 42–64% relative humidity)
with 12h light and dark cycles. After a 7-day acclimation, the body weight of each
rat was measured and assigned to the study. Their body weight was in the range of
288–336g at intratracheal instillation.
2.4. General experimental design
Rats were anesthetized with ether, and 1mL/kg body weight of MWCNTs, neg-
ative control, or the positive control (crystalline silica particle) suspension were
instilled into the trachea using a 18G indwelling needle, corresponding to doses of
0.04, 0.2, or 1mg/kg body weight of MWCNTs and 5mg/kg body weight of crys-
talline silica particles. Following instillation, the viability and general condition of
the rats were observed once a day until dissection. The body weight of each rat was
measured before instillation and at 1-, 3-, 7-, 14-, 21-, 28-, 35-, 42-, 49-, 56-, 63-,
70-, 77-, 84-, and 91-day post-exposure. Measurements of the organ weight of the
left lung, bronchoalveolar lavage ﬂuid (BALF) examination from the right lung, and
histopathological evaluation of the left lung, liver, kidney, spleen, and cerebrum
were performed at 3-day, 1-week (7 days), 1-month (28 days), and 3-month (91
days) post-exposure. Five rats per group were evaluated at each time point.
Animal experiments were performed in 2009 at the Kashima Laboratory, Mit-
subishi Chemical Medience Corp. (Tokyo, Japan) in accordance with the Law for
Partial Amendments to the Law Concerning the Protection and Control of Animals
(2005). This studywasapprovedby the InstitutionalAnimalCareandUseCommittee
of theTesting Facility andperformed in accordancewith the ethics criteria contained
in the bylaws of the Committee of National Institute of Advanced Industrial Science
and Technology.
2.5. Bronchoalveolar lavage
The rats were euthanized by administrating an intraperitoneal injection of pen-
tobarbital sodium (Nembutal injectable, Dainippon Sumitomo Pharma Co., Ltd.,
Tokyo, Japan) followed by exsanguination. The left bronchus was clampedwith for-
ceps, and the right bronchuswas cannulated. Subsequently, 3mL of heated (∼37 ◦C)
saline (Otsuka Pharmaceutical Factory, Inc., Tokushima, Japan) was instilled and
aspirated to and from the lung to recover the ﬁrst BALF fraction (approximately
2mL). The supernatantwas obtained by centrifuging the BALF at 300g for 5min and
was used for the biochemical and cytokinemeasurements. Thereafter, 2mL of saline
solution was instilled and aspirated to and from the lung twice, and then additional
BALF (approximately 4mL) was obtained, centrifuged at 300g for 5min after addi-
tion to the precipitation obtained by centrifugation of the ﬁrst BALF. The cell fraction
was used to determine cell counts in the BALF.
2.6. Pulmonary cell counts
The cell fractions were suspended in saline with addition of BSA (0.1%) and
EDTA-2K (0.05mM) dissolved in PBS, and the number of total cells, neutrophils,
macrophages, lymphocytes, and eosinophils were counted with an automatic ery-
throcyte analyzer (XT-2000iV, Sysmex Corporation, Hyogo, Japan).
2.7. Biochemical measurements
Lactate dehydrogenase (LDH) and total protein (TP) concentrations in the super-
natant obtained by centrifugation of the BALF were measured with an automatic
biochemical analyzer (TBA-200FR, Toshiba Medical Systems Corporation, Tochigi,
Japan). Interleukin (IL)-1, IL-1, IL-2, IL-4, IL-6, IL-10, IL-12, granulocytemonocyte
colony stimulating factor (GM-CSF), interferon (IFN)-, and tumor necrosis factor
(TNF)- concentrations were measured using a Rat Cytokine 10-Plex A Panel kit
and Bio-Plex Suspension Array System (Bio-Rad Laboratories, Inc., Tokyo, Japan).
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an ultrasonic bath is effective for dispersing MWCNTs into the
Tween 80 solution. Distribution of the MWCNT length in the
1mg/mL of MWNT suspension, which is measured based on the
SEM images, is shown in Fig. 2. The length of the all MWC-ig. 1. SEM and TEM images of MWCNTs samples. SEM images of bulk MWCNTs
ltrasonication with an ultrasonic bath.
.8. Histopathological evaluation
The trachea, left lung, liver, kidney, spleen, and cerebrum were ﬁxed with
0% (v/v) neutral phosphate-buffered formalin solution, embedded in parafﬁn, sec-
ioned, and stained with hematoxylin and eosin for histopathological evaluation
nder the light microscope.
.9. Light and electron microscopic observation of MWCNTs in the lung
Morphology of theMWCNTs in the lungwas observedwith the lightmicroscope.
ections of the right lung after lavage were ﬁxed with glutaraldehyde and were
esin-embedded to give ultrathin sections. Morphology of the individual tubes of
nstilled MWCNTs in the lung of rats was observed with TEM (JEM-100CX II, JEOL
td., Tokyo, Japan).
.10. Statistical analyses
Statistical analyses of the body and lung weights, as well as the cell numbers
nd biochemical parameters in the BALF were conducted. Statistical signiﬁcance
as determined using multiple comparison tests between the negative control and
WCNT-exposed groups. First, the Bartlett’s test was conducted. One-way layout
nalysis of variance was conducted when the variances were equal. Further, Dun-
ett’s multiple comparison tests were conductedwhen the differences between the
roups were signiﬁcant. The Kruskal–Wallis test was usedwhen the variances were
ot equal and Steel’s multiple comparison tests were conducted when the differ-
nceswere signiﬁcant. Statistical signiﬁcancewas determined between the positive
nd negative control groups using intergroup comparison tests. First, the F-test was
onducted; the Student’s t-test was used when the variances were equal, and the
spin–Welch t-test was used when the variances were not equal. Statistical sig-
iﬁcances were judged at the 0.05 probability level. SAS System version 6.12 (SAS
nstitute Japan Ltd., Tokyo, Japan) was used for all the statistical analyses.
. Results.1. MWCNT characterization
SEMandTEM images of thebulk anddispersedMWCNTsamples
re shown in Fig. 1. In the bulk MWCNT samples, MWCNTs were
n the form of agglomerates with sizes ranging from 50 to 100m,els a and b). SEM (panel c) and TEM (panel d) images of MWCNTs dispersed by
which are formed from tangled individual tubes with lengths of
more than 10m (Fig. 1a). Objects other than ﬁbrous shape mate-
rials (sizes less than 1m), which were considered to be carbon
soot, were also observed in the bulk MWCNT samples (Fig. 1b).
Their content was 7–8% by weight and catalysts were not detected
(<0.1% by weight), based on results from the TG analysis. The BET
surface area of the bulk MWCNTs was 23.0m2/g.
Most of the MWCNTs in the suspension were individually dis-
persed (Fig. 1c and d), which suggests that ultrasonication withFig. 2. Distribution of MWCNT length in a 1mg/mL MWCNT suspension dispersed
by ultrasonication in an ultrasonic bath.
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Ts in the suspension was less than 20m, whereas longer
ubes were present in the bulk sample. These results suggest that
he MWCNTs were cut during ultrasonication. Generally ultra-
onication processes can cause a degradation in sample quality
y introducing defects in the graphene structure of MWCNT
nd producing carbon debris. In order to evaluate this degra-
ation, an effective method is calculation of D/G ratio, the
atio of the intensities of disorder-induced mode (D-band) and
raphene-induced mode (G-band) which are appeared in the
aman spectrum of MWCNT (Lee et al., 2008; Musumeci et
l., 2008). The D/G ratio of the bulk MWCNT samples and the
ispersed MWCNT suspension showed quite similar values of
.091 and 0.085, respectively. This result implies that there are
ot signiﬁcant degradation in sample quality after the ultrason-
cation process even the MWCNT ﬁbers were cut into shorter
egments.
.2. Body and lung weightsStatistically signiﬁcant differences in the bodyweights of exper-
mental animals were not observed between any of the MWCNT or
rystalline silica-exposed groups and the negative control group at
ny time point.
ig. 4. Total number of BALF cells (a), neutrophils (b), macrophages (c), lymphocytes
WCNTs, crystalline silica particles, or the corresponding controls at 3-day, 1-week, 1-m
he mean± SD. *Signiﬁcant increase from control (p<0.05).Fig. 3. Left lung weights of rats exposed to MWCNTs or crystalline silica particles
and the corresponding controls at 3-day, 1-week, 1-month, 3-month, and 6-month
post-instillation exposure. Values are represented as the mean± SD. *Signiﬁcant
increase from control (p<0.05).
Throughout the study period, no obvious increase in the lung
weight was observed in any of the MWCNT-exposed groups when
compared with the lung weight in the negative control group. In
contrast, lung weight was signiﬁcantly greater in the crystalline
silica-exposed group (Fig. 3).
(d), and eosinophils (e), and the percentage of neutrophils (f) in rats exposed to
onth, 3-month, and 6-month post-instillation exposure. Values are represented as
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-month post-instillation exposure. Values are represented as the mean± SD. *Sign
.3. Necropsy ﬁndings
In the negative control group and the group exposed to
.04mg/kg MWCNTs, abnormal ﬁndings were not observed at any
f the time points. In the groups exposed to 0.2 and 1mg/kg
WCNTs, brown or black spots were observed in the lung until
- and 6-month post-exposure, respectively. These spots were
onsidered to be the pigment of the agglomerated MWCNTs. In
he crystalline silica-exposed group, signiﬁcant changes were not
bserved until 1-month post-exposure, white spots were observed
n the lung from 3- to 6-month post-exposure, and hypertrophy
f the peribronchial lymph nodes and thymic lymph nodes was
bserved.
ig. 6. Light micrographs of lung tissues of rats exposed to MWCNTs at 1-month post-in
bserved in the group exposed to 0.04mg/kg MWCNTs (panel a). Minimal macrophage ac
xposed to 0.2mg/kg MWCNTs (panel b). MWCNT deposits and macrophage accumulatio
nd d).particles, or the corresponding controls at 3-day, 1-week, 1-month, 3-month, and
t increase from control (p<0.05).
3.4. BALF results
3.4.1. Inﬂammatory cells
In the MWCNT-exposed groups, the number and percentage
of BALF inﬂammatory cells were changed in a dose-dependent
manner (Fig. 4). While no changes were observed in the group
exposed to 0.04mg/kg MWCNTs. BALF neutrophils were increased
signiﬁcantly only at 3-day post-exposure in the group exposed
to 0.2mg/kg MWCNTs. In the group exposed to 1.0mg/kg MWC-
NTs, the total BALD cell numbers, neutrophils, eosinophils, and
the percentage of neutrophils were increased signiﬁcantly only at
3-day post-exposure. In the crystalline silica-exposed group, the
total BALF cell numbers, neutrophils, lymphocytes, eosinophils, and
stillation exposure (hematoxylin and eosin staining). No signiﬁcant changes were
cumulation and phagocytosed MWCNTs were observed in the alveoli of the group
n were observed in the alveoli of the group exposed to 1mg/kg MWCNTs (panels c
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Table 1
Pulmonary histopathology severity scoresa of rats exposed to MWCNTs or silica.
Findings Timepoint Control group MWCNT-exposed group Silica-exposed group
0.04mg/kg 0.2mg/kg 1mg/kg
Administered substance
accumulation in the alveoli
3 d 0 0 1 1 1
1 wk 0 0 1 1.4 0.8
1 mo 0 0 0.6 1 1
3 mo 0 0 0.4 1 0
6 mo 0 0 0.6 1 0
Administered substance
accumulation in the
interstitium
3 d 0 0 0 0.6 1
1 wk 0 0 0 0.8 0
1 mo 0 0 0.2 0.4 0
3 mo 0 0 0.2 0.4 0
6 mo 0 0 0 1.2 0
Inﬂammatory cell inﬁltration
in the alveoli
3 d 0.2 0.2 0.8 0.8 0.6
1 wk 0 0 0.4 0.4 0
1 mo 0.4 0 0 0 0.2
3 mo 0 0 0 0 0.6
6 mo 0 0 0 0 1
Macrophage accumulation in
the alveoli
3 d 0.6 0.2 1 1.4 1
1 wk 0.2 0 1 1.4 0.8
1 mo 0.2 0 0.8 1 1
3 mo 0 0 0.4 1 1.8
6 mo 0 0 0.6 1 2
Macrophage inﬁltration in the
interstitium
3 d 0.4 0 0.6 1.2 1
1 wk 0.2 0 0.2 1.2 0
1 mo 0 0 0.2 0.4 0.6
3 mo 0 0 0.2 0.4 1
6 mo 0 0 0 1.2 0.3
Granuloma in the interstitium 3 d 0.4 0 0.6 0.4 0.2
1 wk 0 0 0 0.4 0
1 mo 0 0 0.2 0.4 0
3 mo 0 0 0 0 0.2
6 mo 0 0 0 0.4 0.8
Granuloma in the lymphoid
tissue
3 d 0 0 0 0 0
1 wk 0 0 0 0 0
1 mo 0 0 0 0 0
3 mo 0 0 0 0 0
6 mo 0 0 0 0 1
Hypertrophy of the bronchial
epithelium
3 d 0 0 1.4 1 0
1 wk 0 0 0 0.2 0
1 mo 0 0 0 0 0
3 mo 0 0 0 0 0
6 mo 0 0 0 0 0
Hypertrophy of the alveolar
epithelium
3 d 0 0 0 0 0
1 wk 0 0 0 0 0
1 mo 0 0 0 0 0
3 mo 0 0 0 0 0.8
6 mo 0 0 0 0 1.8
Macrophage cytolysis in the
alveoli
3 d 0 0 0 0 0
1 wk 0 0 0 0 0
1 mo 0 0 0 0 0.2
3 mo 0 0 0 0 1.8
6 mo 0 0 0 0 1.8
Foamy macrophage inﬁltration
in the alveoli
3 d 0 0 0 0 0
1 wk 0 0 0 0 0
1 mo 0 0 0 0 0
3 mo 0 0 0 0 1.4
6 mo 0 0 0 0 1.3
Alveolar proteinosis 3 d 0 0 0 0 0
1 wk 0 0 0 0 0
1 mo 0 0 0 0 0
3 mo 0 0 0 0 1.2
6 mo 0 0 0 0 1.8
a Severity scores given to individual animals from a complete pathological examination are 0, not remarkable; 1, minimal; 2, slight/mild; 3, moderate; and 4, severe; based
upon relative evaluation of lesions. Severity scores for each animal within a group were added, and an average score per animal was calculated, which is shown in the table.
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gig. 7. Light micrographs of lung tissues of rats exposed to MWCNTs at 6-month p
bserved in the group exposed to 0.04mg/kg MWCNTs (panel a). Minimal macroph
xposed to 0.2mg/kg MWCNTs (panel b). MWCNT deposits and macrophage accum
WCNTs (panel c). Minimal MWCNT depositions (arrows) were observed in the pe
he percentage of neutrophils were signiﬁcantly increased until
-month post-exposure.
.4.2. Biochemical measurements
For the MWCNT-exposed groups, LDH and TP levels in the BALF
ere signiﬁcantly increased only in the group exposed to 1mg/kg
WCNTs;however, the changeswere transient and recoveredafter
-weekpost-exposure (Fig. 5). BALF cytokine levelswerenot signif-
cantly changedat any timepoint (datanot shown). In contrast, LDH
ndTP levels in theBALFwere signiﬁcantly increaseduntil 6-month
ost-exposure in the crystalline silica-exposed group (Fig. 5), and
igniﬁcant changes in IL-1 and IL-2 levels were observed in this
roup (data not shown).
.5. Histopathological evaluation
For all the groups, histopathological changes due to the instilla-
ion exposure of MWCNTs or crystalline silica were observed only
n the lungs and lung-associated lymph nodes, and not in the other
issues (i.e., the liver, kidney, spleen, and cerebrum). Table 1 sum-
arizes the histopathological ﬁndings of the rats examined in this
tudy and their severity scores at each time point.
In theMWCNT-exposedgroups,dose-dependenthistopatholog-
cal changes were observed. In the group exposed to 0.04mg/kg
WCNTs, no signiﬁcant changes were observed at any time points
Figs. 6 and 7Figs. 6a and 7a). In the group exposed to 0.2mg/kg
WCNTs, minimal macrophage accumulation and phagocytosed
WCNTs were observed in the alveoli (Figs. 6b and 7b). In the
roup exposed to 1mg/kg MWCNTs, deposition of the MWCNTsstillation exposure (hematoxylin and eosin staining). No signiﬁcant changes were
cumulation and phagocytosed MWCNTs were observed in the alveoli of the group
on were observed in the alveoli and interstitium of the group exposed to 1mg/kg
chial lymph nodes in the group exposed to 1mg/kg MWCNTs (panel d).
andmacrophage accumulation, part ofwhichwere granulomatous,
was observed in the alveoli and interstitium from3-day to 1-month
post-exposure (Fig. 6c and d). Most MWCNTs were phagocytosed
by alveolar macrophages. Further, hypertrophy of the bronchial
epitheliumand inﬂammatory cell inﬁltrationswereobserved. From
3- to6-monthpost-exposure, histopathological ﬁndingswerequal-
itatively similar to those at 1-month post-exposure; although
the severity of the changes was gradually weaker. At 6-month
post-exposure, deposition of the MWCNTs and macrophage accu-
mulation, part of which were granulomatous, was observed in the
alveoli and interstitium in the group exposed to 1mg/kgMWCNTs;
however, the severity of these changes was minimal (Fig. 7c). In
the group exposed to 1mg/kg MWCNTs, minimal MWCNT deposi-
tions were observed in the peribronchial lymph nodes at 6-month
post-exposure (Fig. 7d).
In the crystalline silica-exposed group, only minimal
macrophage accumulation in the alveoli and interstitium was
observed up to 1-week post-exposure. However, the severity of
macrophage accumulation was increased after 1-month post-
exposure, and, cytolysis of macrophages was observed, which
was most severe at 6-month post-exposure. At 6-month post-
exposure, in addition to the inﬁltration of inﬂammatory cells,
foamy macrophages and cytolysis of macrophages were observed
in the alveoli; pulmonary alveolar proteinosis was induced
(Fig. 8a). Hypertrophy of the alveolar epithelium and granulomas
was observed in the interstitium (Fig. 8b). Multifocal granulomas
were also observed in the intrapulmonary lymph nodes (Fig. 8c),
peribronchial lymph nodes (Fig. 8d), and thymic lymph nodes
(data not shown).
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nig. 8. Light micrographs of lung tissues of rats exposed to crystalline silica partic
acrophages and foamymacrophage inﬁltrations were observed in the alveoli; pulm
n the interstitium (panel b). Multifocal granulomas were observed in the intrapulm
The results of the histopathological evaluationswere consistent
ith that of BALF inﬂammatory cells and biochemical measure-
ents.
.6. Light and electron microscopic observation of MWCNTs in
he lungs
On the basis of light microscopic examination, MWCNTs
eposited in the lungswerephagocytosedbyalveolarmacrophages
nd were sequentially accumulated in the alveoli or interstitium
ntil 6-month post-exposure (Fig. 9). Furthermore, the 400 TEM
mages, which displayed individual MWCNTs, showed that all the
WCNTs were presented in a similar form in the lungs. MWCNTs
ere located in the alveolarmacrophages or inmacrophages in the
nterstitial tissues, and individualMWCNTswere not present in the
ells of the interstitial tissue (Fig. 10). The diameter and length of
he 104 tubes in the TEM images were measured. The diameter of
heMWCNTs in the lungswasalmost the sameas the instilledmate-
ials (approximately 60nm). There were a wide range of MWCNT
engths in the lungs; the median length was approximately 1.5m
number basis), although some tubes were considerably longer,
easuring up to 6m (Fig. 11).
. DiscussionBiological responses due to the single instillation of MWCNTs
ere observed only in the lungs of rats, and not in the liver, kidney,
pleen, or cerebrum (including the olfactory bulb) in all the groups.
ALF inﬂammatory cells as well as LDH and TP levels were sig-
iﬁcantly increased in the group exposed to 1mg/kgMWCNTs, but6-month post-instillation exposure (hematoxylin and eosin staining). Cytolysis of
y alveolar proteinosis was induced (panel a). Granuloma formations were observed
lymph nodes (panel c) and peribronchial lymph nodes (panel d).
only at 3-day post-exposure. No signiﬁcant changes in BALF inﬂam-
matory cells and markers were observed in the groups exposed
to 0.04 and 0.2mg/kg MWCNT at any time points. The severity of
the lesions on histopathological examination of rat lungs was dose
dependent althoughWarheit et al. (2004) andMitchell et al. (2007)
have reported non-dose-dependent pulmonary responses due to
instillation of SWCNTs or inhalation ofMWCNTs. Histopathological
evaluation indicated deposition of the MWCNTs and macrophage
inﬁltration, part of which were granulomatous, in the alveoli and
interstitium in the group exposed to 1mg/kg MWCNTs. On the
basis of the light microscopic observations, MWCNTs were phago-
cytosed by macrophages. Hypertrophy of the bronchial epithelium
and inﬂammatory cell inﬁltrations were also observed in this
group. Some of the previous toxicity studies of MWCNT instilla-
tion or inhalation exposures in rats (Muller et al., 2005; Li et al.,
2007; Ma-Hock et al., 2009; Pauluhn, 2010) have reported qualita-
tively similar pulmonary responses. However, our study revealed
that pulmonary inﬂammatory responses were transient, and the
histopathological changes were gradually weaker from 1-week
to 6-month post-exposure. At 6-month post-exposure, signiﬁcant
changes were not observed in the group exposed to 0.2mg/kg
MWCNTs. In the group exposed to 1mg/kg MWCNTs, deposi-
tion of the MWCNTs and macrophage accumulation, of which
some of them were granulomatous, were observed in the alve-
oli and interstitium until 6-month post-exposure, although they
were minimal changes. Studies have reported that pulmonary
ﬁbrosis is induced due to exposure to SWCNTs or MWCNTs
(Muller et al., 2005; Shvedova et al., 2008a); however, pul-
monary ﬁbrosis was not observed in any of the groups in this
study.
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nd were sequentially accumulated in the alveoli until 6-month post-instillation.
Light microscopy and TEM observations revealed that the
WCNTs deposited in the lungs were phagocytosed by alveolar
acrophages and were sequentially accumulated in the alve-
li. MWCNT translocation or penetration to the pleural was not
bserved. Furthermore, basedon the400TEM images, itwas shown
hat all the MWCNTs were located in the alveolar macrophages or
hagocytosed by macrophages in the interstitial tissues, and indi-
idual MWCNTs were not presented in the cells of the interstitial
issue.
In contrast, inﬂammatory responses were observed in the lungs
nd lung-associated lymph nodes in the group exposed to 5mg/kg
rystalline silica, where BALF inﬂammatory cells, LDH, TP, IL-1,
nd IL-2 levels were signiﬁcantly increased after the instillation
xposure, and these changeswere themost severeat6-monthpost-
xposure. Furthermore, lung weights were signiﬁcantly increased
t 3- and 6-month post-exposure. Histopathological evaluation
evealed that although short-term inﬂammatory responses were
eak, the inﬂammatory responsesweremuch stronger at 6-month
ost-exposure. Consequently, crystalline silica particles produced
ontinuous inﬂammation with a 5mg/kg dose of intratracheal
nstillation. These pulmonary responses were qualitatively and
uantitatively different from the responses observed for MWCNTs
nstillation exposure.
The relationship of the dose of MWCNTs instilled into the
ungs in this study and exposure levels of aerosolized MWCNTs
o humans during the handling of CNTs in the work place is dis-
ussed below. The pulmonary deposition amount of MWCNTs in
his studywas considered to be almost 100% of the instilled dose of
he MWCNTs (i.e., 0.04, 0.2, and 1.0mg/kg). By measuring the BET
urface area of the MWCNT samples, the doses can be expressedat 3-day (panel a), 1-week (panel b), 1-month (panel c), and 6-month (panel d)
NTs deposited in the lungs were typically phagocytosed by alveolar macrophages
in terms of the CNT surface area dose, which are 0.0009, 0.1146,
and 0.023m2/kg, for doses of 0.04, 0.2, and 1.0mg/kg, respec-
tively. Based on the density of the MWCNT samples reported by
the manufacturer (2.1 g/cm3) and assuming that the tube diame-
ter and length are uniform (60nm and 1.5m, respectively), and
that all tubes are individually dispersed in the suspension, the
doses can also be expressed in terms of tube numbers, which are
9.4×109, 4.7×1010, and 2.4×1011 tubes/kg, for dosed of 0.04, 0.2,
and 1.0mg/kg, respectively.
On the other hand, there are only a few reports of atmospheric
CNT concentrations measurements in the work place. Maynard et
al. (2004) and Han et al. (2008) reported measured concentrations
of SWCNTs and MWCNTs in the research facilities, respectively.
Maynard et al. (2004) reported that atmospheric concentra-
tions of SWCNTs, which were estimated using an indicator of
metal catalysts, were in range of 0.7–53g/m3 during the collec-
tion and cleaning process, based on the investigation of SWCNT
research facilities with laser-abrasion or the high pressure car-
bon monoxide (HiPco) method. Han et al. (2008) reported that
the atmosphericmass concentration of total dust (includingMWC-
NTs) was in range of 210–430g/m3 during the blending process
and in range of 37–190g/m3 during the weighing and spraying
process, based on the investigation of MWCNT research facili-
ties with the thermal chemical vapor deposition (CVD) method.
They also reported that the number concentration of MWCNTs
was in rangeof172.9–193.6×106 tubes/m3 during theseprocesses.
Based on the atmospheric mass concentration or number con-
centration of CNTs reported in these studies, deposition amounts
of MWCNTs to the lungs of humans working for 8h/day and 5
days/week without any exposure protection can be calculated as
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(ig. 10. TEM images of the lungs of rats exposed to 1mg/kg of MWCNTs at 1-week
xposure (magniﬁcation: ×10,000). MWCNTs observed in TEM images were located
ollows. Assuming that average daily exposure time is 8h/day×5
ays/week×60min/h=343min/day, the deposition fraction of
nhaled MWCNTs into the lungs is 0.1 (10%) based on the study
f Miller (2000), the respiratory minute volume is 25 L/min, and
odyweight is 60kg, thenpulmonarydeposition amounts ofMWC-
Ts are calculated to be 0.01 and 6.2g/kg/day, based on the
tmospheric concentration of 0.7g/m3 (Maynard et al., 2004) and
34.5g/m3 (Han et al., 2008), respectively. Therefore, instillation
xposure of 1.0mg/kg MWCNTs corresponds to pulmonary depo-
ition amounts of 160–1300 days (i.e., several months to several
ears) in the working environment without any exposure protec-
ion when the maximum atmospheric concentration of MWCNTs
s used in the calculation.
ig. 11. Length of MWCNTs in the lungs of rats exposed to 1mg/kg MWCNTs.
he lengths of 104 MWCNTs observed by the TEM were measured. The median
minimum–maximum) length of the MWCNTs in the lungs was 1.5 (0.42–6.1) m.l a), 1-month (panel b), 3-month (panel c), and 6-month (panel d) post-instillation
e alveolar macrophages and not in the interstitial cells.
Based on the number concentration of CNTs, deposition of
MWCNTs into the lungs per dayper kg bodyweightwere calculated
to be 2.47–2.77×106 tubes/kg/day based on the atmospheric num-
ber concentration of 172.9–193.6×106 tubes/m3 (Han et al., 2008).
Therefore, 2.4×1011 tubes/kg (1.0mg/kg) of instillation exposure
of MWCNTs corresponds to a pulmonary deposition amount of
85,000–95,000 days, which is longer than the average human lifes-
pan.
Collectively, our data indicated that the pulmonary inﬂam-
matory responses to MWCNT deposition in the lungs were dose
dependent, and the responses were weak and transient under
approximate pulmonary deposition amounts comparable to the
work environment. Chronic inﬂammatory responses such as pul-
monary ﬁbrosis or angiogenesis were not observed. MWCNTs
deposited in the lungs were mostly phagocytosed by alveolar
macrophages and were sequentially accumulated in the alveoli,
which suggests that MWCNTs were being processed and cleared
by alveolar macrophages.
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